http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009246204-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42a9341203c355f522dca60ceb10a814
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36
filingDate 2008-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_545ac55e0d8ff1b7b4f921eca9b05ca5
publicationDate 2009-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2009246204-A1
titleOfInvention Use of a cd28 binding substance for making a pharmaceutical composition
abstract The invention relates to the use of a CD28-specific superagonistic monoclonal antibody (mAb) or of a mimicry compound hereto for making a pharmaceutical composition for the induction and/or multiplication of regulatory T cells.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4108183-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021119482-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11591401-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023278641-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018183929-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020106704-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020106754-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020106750-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020106757-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019246312-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019246317-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021127217-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020227159-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4252629-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019241730-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022212784-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022006179-A1
priorityDate 2002-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003166860-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6987171-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525

Total number of triples: 49.